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Between April 1992 and April 1994, 185 patients were waiting fora cardiac transplant at
our institution. Transplantation was performed in 118 of these patients. Twenty-six pa-
tients (14%) died while awaiting a donor heart: 13 of these were in the intensive care
unit on multiple inotropic medications, mechanical support, or both; another 13 were
either in the hospital on a single inotropic medication or at home with or without inotro-
pic support. The remaining 41 patients were still awaiting transplantation at the end of
the study period.
During the same interval, 20 comparably ill patients who were referred to our institu-
tion for transplantation were considered for high-risk conventional surgical procedures.
These patients underwent clinical evaluation to determine whether they had viable muscle
that was salvageable and electrophysiologic status that was alterable. On this basis,
these 20 patients underwent a variety of combined high-risk procedures. Two patients
died; the operative mortality was 5% and the cumulative mortality was 10%. We con-
clude that these initial results support our original impression that mortality rates are
higher in patients waiting for cardiac donation than in patients undergoing high-risk sur-
gical procedures. Therefore, we will continue to investigate high-risk conventional sur-
gery as an alternative to cardiac transplantation. (Texas Heart Institute Journal 1994;
21:302-4J
T he current medical climate, which includes ever-increasing scrutiny of op-
erative mortality, outcome analysis, and surgical statistics in general, may
have caused many surgeons, consciously or not, to decrease their level
of risk-taking in planning treatment strategies. These factors, coupled with the
option of cardiac transplantation, with its excellent short- and intermediate-term
results, may have encouraged over-reliance on transplantation. We report our ex-
perience in redirecting appropriate patients to high-risk conventional procedures.
This redirection was prompted by the impression that we were experiencing in-
creasing mortality in patients awaiting transplantation.
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Patients and Results
Between April 1992 and April 1994, 185 patients were awaiting a donor heart in
the transplant program at our institution. Of these, 118 patients underwent trans-
plantation: 72 as Status I* and 46 as Status II or III.* Twenty-six died while waiting
for a cardiac donor: 13 as Status I and 13 as Status II or III, for an overall mortality
of 14% in patients awaiting transplantation. The remaining 41 patients were still
waiting for a heart transplant at the end of the study period.
During this same interval, another group of patients was offered high-risk con-
ventional surgery as an alternative to transplantation. This study population com-
prised 20 patients, ranging in age from 50 to 72 years, with an average age of 60.
Only 2 of the 20 patients had experienced any recent angina. At presentation, all
the patients were in congestive heart failure, New York Heart Association func-
tional class III or IV. At the time of evaluation, 5 required an intra-aortic balloon
pump, 9 required inotropic support, and 6 had a history of recurrent ventricular
tachycardia or of sudden death. Ejection fractions ranged from 12% to 35% with
an average of 21%. In 5 patients, severe mitral insufficiency was present. These
* Status I indicates that the patient is in the intensive care unit on multiple inotropic medications and/
or mechanical support. Status II indicates single inotropic medication at home or in the hospital.
Status III indicates at home.
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same patients represented the higher ejection frac-
tions, and thereby may have falsely elevated the val-
ues.
In the 20 study patients, preoperative evaluation
to determine myocardial viability included thallium
perfusion studies, dobutamine stress echocardiog-
raphy, and technetium-99m-sestamibi studies. Five
patients underwent preoperative electrophysiologic
studies.
Of the 20 patients studied, 9 underwent coronary
artery bypass alone. Table I presents the procedures
performed in the other 11 patients, either alone or
in combination, including bypass, valve replace-
ment, cardioverter-defibrillator implantation, aneu-
rysm resection, and endocardial resection.
The operative mortality was 5%, and the cumula-
tive mortality was 100/o. The 1 operative death oc-
curred 3 months after surgery. The patient, who had
undergone mitral valve replacement and coronary
artery bypass surgery, died of multisystem failure
after prolonged treatment for nonoliguric renal fail-
ure. A 2nd patient also died at 3 months, following
a ventricular tachycardiac storm. This patient had
undergone coronary artery bypass and placement of
an automatic intemal cardioverter-defibrillator; the
device, on follow-up investigation, appeared to be
functioning norrnally.
Morbidity in the study population was minimal.
One patient required a brief period of reintubation
in the early postoperative period, and another pa-
TABLE 1. Procedures Performed Alone or in Combina-
tion in the High-Risk Surgical Group (n=20)
Number of
Patients Procedures
9 Coronary artery bypass graft
3 Combined: Mitral valve replacement;
Coronary artery bypass graft
2 Combined: Coronary artery bypass graft;
Automatic internal cardioverter-defibrillator
1 Combined: Mitral valve replacement;
Coronary artery bypass graft; Automatic
internal cardioverter-defibrillator
1 Redo aortic valve replacement
1 Redo mitral valve replacement
1 Combined: Aneurysm resection; Coronary
artery bypass graft
1 Combined: Aneurysm resection and
cryoablation; Coronary artery bypass graft;
Automatic internal cardioverter-defibrillator
1 Combined: Aneurysm resection; Endocardial
resection; Automatic internal cardioverter-
defibrillator
tient underwent several days of aggressive treatment
for congestive heart failure after an episode of atrial
fibrillation that resulted in deterioration of his con-
dition.
All 18 surviving study patients were in New York
Heart Association functional class I or II at an aver-
age follow-up period of 12.3 months. Long-term fol-
low-up on 12 of these patients (67%) revealed ejec-
tion fractions of 35% to 40%.
Discussion
In this study, we compared the mortality rates of
patients awaiting cardiac transplantation with the
mortality rates of comparably ill patients who un-
derwent high-risk conventional surgery. Of the 185
patients awaiting a donor heart, 118 received a trans-
plant during the study period and 67 did not. Of
those 67, 41 were still waiting for a donor heart at
the end of the study period, and 26 had died. Those
deaths represented 14% of the original group await-
ing transplant. In the group of 20 patients undergo-
ing high-risk conventional surgery, 2 patients died,
for a mortality rate of 10%.
Several factors are currently challenging cardiac
transplantation. The recipient population is growing
due to increased acceptance of the efficacy of trans-
plantation by the public and medical professionals
alike. In addition, refinement of the transplant pro-
cedure and of postoperative care has expanded the
recipient criteria, which in turn has dramatically in-
creased the number of eligible recipients. Unfortu-
nately, the number of donor hearts is still limited,
despite all efforts by medical professionals and or-
gan procurement organizations to increase consent
rates.' Moreover, the progress, development, and
approval of mechanical assist devices and total arti-
ficial hearts have been relatively slow.
All these factors lead to a dilemma for potential
transplant recipients and their physicians: as the
waiting time increases, the mortality of those on the
waiting list increases as well. There are a number of
strategies for managing the growing recipient popu-
lation (Table II). Expansion of the number of poten-
tial cardiac donors by broadening the acceptance
criteria is one possibility.2-8 Surgical alternatives to
transplantation, such as cardiomyoplasty in the for-
mation of skeletal muscle ventricles, continue to be
developed and tested through clinical trials. Three
programs-at the Texas Heart Institute, the Cleve-
land Clinic Foundation, and the Hershey Medical
Center-have been funded to continue work on the
total artificial heart. And finally, high-risk conven-
tional procedures are being reconsidered in the pro-
posed transplant patient population.
This last approach prompted us to ask whether
patients referred for transplantation could undergo
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TABLE II. Strategies to Manage a Growing Transplant
Recipient Population
* Expansion of donor pool by expanded acceptance criteria
* Surgical alternatives to transplantation (cardiomyoplasty:
skeletal muscle ventricles)
* Development of long-term assist devices, such as the
total artificial heart
* Reconsideration of high-risk conventional procedures in
the proposed transplant recipient population
high-risk surgical procedures with an acceptable
operative mortality and postoperative clinical func-
tional status. From our clinical results and impres-
sions, we conclude that efforts should be made in
severely ill cardiac patients to perform high-risk
conventional surgery when evaluation suggests the
presence of salvageable muscle and alterable elec-
trophysiologic status.
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